z-logo
Premium
Pharmacogenomics Implementation: Considerations for Selecting a Reference Laboratory
Author(s) -
Vo Teresa T.,
Bell Gillian C.,
Owusu Obeng Aniwaa,
Hicks J. Kevin,
Dunnenberger Henry M.
Publication year - 2017
Publication title -
pharmacotherapy: the journal of human pharmacology and drug therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.227
H-Index - 109
eISSN - 1875-9114
pISSN - 0277-0008
DOI - 10.1002/phar.1985
Subject(s) - pharmacogenomics , reimbursement , medical laboratory , medical physics , health care , selection (genetic algorithm) , computer science , medicine , data science , pathology , pharmacology , artificial intelligence , economics , economic growth
One of the initial steps for implementing pharmacogenomics into routine patient care is selecting an appropriate clinical laboratory to perform the testing. With the rapid advances in genotyping technologies, many clinical laboratories are now performing pharmacogenomic testing. Selection of a reference laboratory depends on whether a particular genotype assay is already performed by an internal health care organization laboratory or only available externally. Other factors for consideration are coverage of genomic variants important for the patient population, technical support, and cost. In some instances, the decision to select a particular reference laboratory may be the responsibility of the clinician who is recommending genomic interrogation. Only limited guidance is available that describes the laboratory characteristics to consider when selecting a reference laboratory. We provide practical considerations for selecting a clinical laboratory for pharmacogenomic testing broadly categorized into four domains: pharmacogene and variant selection; logistics; reporting of results; and test costs along with reimbursement.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here